News

Press release - Venus Medtech to Partner With Pi-Cardia to Bring Its Leaflex™ Aortic Valve Technology to China

PRNewswire

TVT 2019: 
Clinical Experiences with Pi-Cardia Leaflex Aortic Valve Remodeling: An Alternative to TAVR in Some Patients?

Dr. Martin B. Leon 

PCR 2019: 
Safety, Feasibility and Acute Performance of the Leaflex™
Performer when Used Pre TAVI in Aortic Stenosis Patients.
The Leaflex™ Performer Feasibility Study

Prof. Andreas Baumbach

Pi-Cardia’s Leaflex treatment improves aortic stenosis more than balloon valvuloplasty

BioWorld MedTech

“Globes”- Israel business news

T    +972 8 9484800

F    +972 8 9484801

E    info@pi-cardia.net

10 Plaut Street

Science Park, Rehovot 

7670609 Israel

Copyright © 2019 Pi-Cardia. All rights reserved. 

The Leaflex™ Performer is an investigational device

European Union: CAUTION Exclusively for Clinical Investigation